Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the decision rules of cost-effectiveness analysis.

× No keyword cloud information.

35 in total

Review 1. Handling uncertainty in cost-effectiveness models.

Authors: A H Briggs
Journal: Pharmacoeconomics Date: 2000-05 Impact factor: 4.981

2. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors: Laura McCullagh; Cathal Walsh; Michael Barry
Journal: Pharmacoeconomics Date: 2012-10-01 Impact factor: 4.981

3. Efficient use of health care resources: the interaction between improved health and reduced health related income loss.

Authors: Michael Hoel
Journal: Int J Health Care Finance Econ Date: 2002-11

4. The decision rules of cost-effectiveness analysis.

Authors: G Karlsson; M Johannesson
Journal: Pharmacoeconomics Date: 1996-02 Impact factor: 4.981

5. Economic evaluation in healthcare. A brief history and future directions.

Authors: K Blumenschein; M Johannesson
Journal: Pharmacoeconomics Date: 1996-08 Impact factor: 4.981

Review 6. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.

Authors: Yolanda Bravo Vergel; Stephen Palmer; Christian Asseburg; Elisabeth Fenwick; Mark de Belder; Keith Abrams; Mark Sculpher
Journal: Heart Date: 2007-08-23 Impact factor: 5.994

7. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation.

Authors: C M Lambert; N P Hurst; J F Forbes; A Lochhead; M Macleod; G Nuki
Journal: BMJ Date: 1998-03-28

8. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.

Authors: Mark Sculpher; David Millson; David Meddis; Lynne Poole
Journal: Pharmacoeconomics Date: 2002 Impact factor: 4.981

9. A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.

Authors: L Lacey; J Mauskopf; R Lindrooth; S Pham; M Saag; W Sawyer
Journal: Pharmacoeconomics Date: 1999 Impact factor: 4.981

10. Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Authors: Martin Henriksson; Stephen Palmer; Ruoling Chen; Jacqueline Damant; Natalie K Fitzpatrick; Keith Abrams; Aroon D Hingorani; Ulf Stenestrand; Magnus Janzon; Gene Feder; Bruce Keogh; Martin J Shipley; Juan-Carlos Kaski; Adam Timmis; Mark Sculpher; Harry Hemingway
Journal: BMJ Date: 2010-01-19